HDMS Case Study: Three Cost Containment Strategies for GLP-1 Drugs

Why rising GLP-1 costs aren’t going away and what to do about it.  Read more in the HDMS case study.

HDMS-GLP-1-Analytics-case-study

Latest Posts
Partner News
Aon GLP-1 Study: Reduced Rise in Medical Costs for Users, Pronounced Benefits for Women
Across the global technology sector, employers are facing unprecedented complexity—distributed teams, dynamic regulations, and rapidly ...
Read More
Partner News
Novo Nordisk – Time to Take on Obesity in Your Organization
As an employer, take action to help control healthcare costs and improve employee wellness. Obesity ...
Read More
Partner News
nudge: 2026 Global financial wellbeing calendar – Roadmap for supporting every employee everywhere
Financial pressure is reshaping daily life. Globally, people are having to make tough choices: 44% have cut non-essential ...
Read More
Follow SVEF
Scroll to Top

Join the Mailing List

Contact the Team

This field is for validation purposes and should be left unchanged.
Name(Required)